Science
Technology
Environment
Arts & Education
Business
Health
Society
Search
Debulking
Pediatric maxillary mesenchymal chondrosarcoma with HEY1::NCOA2 fusion
Case report of mesenchymal chondrosarcoma in a 13-year-old with HEY1::NCOA2 fusion treated with multimodal therapy including sirolimus targeting mTOR pathway.